Study of oral clofarabine plus low-dose cytarabine in previously treated AML and high-risk MDS patients at least age 60.
K. M. Smith
No relevant relationships to disclose
E. Estey
No relevant relationships to disclose
J. M. Pagel
No relevant relationships to disclose